Marketing drives more testing…more treatments. It’s a big part of why health care is so expensive… it’s the fancy, high-tech stuff things that get marketed.
The app, called Second Chance, detects overdose-related symptoms about 90 percent of the time by tracking your breathing and movement.
When I see a report touting peanut allergy treatments, I devour it, an occupational hazard for a journalist whose reporting and medical history intertwine.
Repeating strings of DNA not easily detected using standard genetic tests appear to cause cases of a rare developmental disorder called Baratela-Scott syndrome.
Some bacteria have an enzyme that can cut the DNA of invading viruses as a defense mechanism. Scientists realized they could use this enzyme to edit human DNA.
The new Apple Watch includes new features designed to detect falls and heart problems.
The high cost of cutting-edge treatments threatens to keep precision medicine, one of the most celebrated areas in cancer care, out of reach for many patients.
As the number of mobile health apps surged to a record 325,000 in 2017, app performance is going largely unpoliced.
Health insurance doesn’t typically cover fertility preservation care, so patients and their families may be deterred by the cost.
Surveys show that the public are optimistic about genome editing for curing diseases, but there can also be a lack of trust about how this technology will be used.